Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)

被引：56
|
作者：
Pfaller, Michael A.
Sader, Helio S. [1 ]
Jones, Ronald N.
机构：
[1] JML Labs, N Liberty, IA 52317 USA
[2] Univ Iowa, Iowa City, IA 52242 USA
[3] Univ Fed Sao Paulo, Div Infect Dis, BR-04023900 Sao Paulo, Brazil
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2007年 / 57卷 / 04期
关键词：
daptomycin; gram-positive infections; Staphylococcus aureus; susceptibility;
D O I：
10.1016/j.diagmicrobio.2006.10.007
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We evaluated the antimicrobial activity of daptomycin against 19 615 clinical strains consecutively collected by numerous centers located across the United States and Canada (2002-2005). Daptomycin was very active against all indicated species (>99% susceptible), with the highest MIC results being 2, 8, 0.5, and 1 mu g/mL for staphylococci, enterococci, beta-hemolytic streptococci, and viridans group streptococci, respectively, and no significant loss in potency was observed over the period studied. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：459 / 465
页数：7
相关论文
共 50 条
  • [31] In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin- Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018-2020
    Xu, Yanlei
    Wang, Bingjie
    Zhao, Huilin
    Wang, Xinyi
    Rao, Lulin
    Ai, Wenxiu
    Yu, Jingyi
    Guo, Yinjuan
    Wu, Xiaocui
    Yu, Fangyou
    Chen, Shuying
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 5449 - 5456
  • [32] In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies
    Krause, Kevin M.
    Barriere, Steven L.
    Kitt, Michael M.
    Benton, Bret M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (02) : 181 - 185
  • [33] In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci
    Citron, DM
    Kwok, YY
    Appleman, MD
    ANAEROBE, 2005, 11 (1-2) : 93 - 95
  • [34] In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital
    Mamtora, Dhruv
    Saseedharan, Sanjith
    Rampal, Ritika
    Joshi, Prashant
    Bhalekar, Pallavi
    Ahdal, Jaishid
    Jain, Rishi
    JOURNAL OF LABORATORY PHYSICIANS, 2020, 12 (03) : 230 - 232
  • [35] Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)
    Sader, Helio S.
    Flamm, Robert K.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (04) : 417 - 422
  • [36] Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019)
    Pfaller, Michael
    Mendes, Rodrigo E.
    Streit, Jennifer M.
    Carvalhaes, Cecilia G.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 104 (04)
  • [37] Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
    Mendes, Rodrigo E.
    Farrell, David J.
    Sader, Helio S.
    Streit, Jennifer M.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 81 (04) : 275 - 279
  • [38] In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci
    Cirioni, Oscar
    Myszka, Henryk
    Dawgul, Malgorzata
    Ghiselli, Roberto
    Orlando, Fiorenza
    Silvestri, Carmela
    Brescini, Lucia
    Kamysz, Wojciech
    Guerrieri, Mario
    Giacometti, Andrea
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (09) : 1337 - 1343
  • [39] In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe
    Carvalhaes, Cecilia G.
    Duncan, Leonard R.
    Wang, Wen
    Sader, Helio S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [40] In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals
    Argudin, M. Angeles
    Dodemont, M.
    Taguemount, M.
    Roisin, S.
    de Mendonca, R.
    Deplano, A.
    Nonhoff, C.
    Denis, O.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 56 - 59
12345